Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Leisenring

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Design issues in studies evaluating diagnostic tests for aspergillosisKieren A Marr, Wendy Leisenring
Breast Cancer Research and Treatment|July 2, 2022
Allogeneic hematopoietic cell transplantation in patients with a hematologic malignancy and a prior history of breast cancerKristine Doney, Wendy Leisenring, Hannah Linden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2009
Empirical versus preemptive antifungal therapy for fever during neutropeniaKieren A Marr, Wendy Leisenring, Eric Bow
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2006
(1-->3) beta -D-glucan assay in the diagnosis of invasive fungal infectionsArlo Upton, Wendy Leisenring, Kieren A Marr
Journal of Cancer Survivorship : Research and Practice|November 26, 2009
Prospective predictors of return to work in the 5 years after hematopoietic cell transplantationAnne C Kirchhoff, Wendy Leisenring, Karen L Syrjala
JAMA Oncology|August 7, 2025
Childhood Cancer Survivor Risk Estimates and Age, Overdispersion, and Social Context-ReplyJennifer M Yeh, Zachary J Ward, Wendy Leisenring
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassayKieren A Marr, Michel Laverdiere, Anja Gugel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2013
Reply to Mikulska et alCynthia E Fisher, Wendy Leisenring, Michael Boeckh, et al.
Biometrics|October 28, 2014
Regression analysis of mixed recurrent-event and panel-count data with additive rate modelsLiang Zhu, Hui Zhao, Jianguo Sun, et al.
American Journal of Epidemiology|April 24, 2004
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening markerMargaret Sullivan Pepe, Holly Janes, Gary Longton, et al.
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Design issues in studies evaluating diagnostic tests for aspergillosisKieren A Marr, Wendy Leisenring
Breast Cancer Research and Treatment|July 2, 2022
Allogeneic hematopoietic cell transplantation in patients with a hematologic malignancy and a prior history of breast cancerKristine Doney, Wendy Leisenring, Hannah Linden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2009
Empirical versus preemptive antifungal therapy for fever during neutropeniaKieren A Marr, Wendy Leisenring, Eric Bow
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2006
(1-->3) beta -D-glucan assay in the diagnosis of invasive fungal infectionsArlo Upton, Wendy Leisenring, Kieren A Marr
Journal of Cancer Survivorship : Research and Practice|November 26, 2009
Prospective predictors of return to work in the 5 years after hematopoietic cell transplantationAnne C Kirchhoff, Wendy Leisenring, Karen L Syrjala
JAMA Oncology|August 7, 2025
Childhood Cancer Survivor Risk Estimates and Age, Overdispersion, and Social Context-ReplyJennifer M Yeh, Zachary J Ward, Wendy Leisenring
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassayKieren A Marr, Michel Laverdiere, Anja Gugel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 19, 2013
Reply to Mikulska et alCynthia E Fisher, Wendy Leisenring, Michael Boeckh, et al.
Biometrics|October 28, 2014
Regression analysis of mixed recurrent-event and panel-count data with additive rate modelsLiang Zhu, Hui Zhao, Jianguo Sun, et al.
American Journal of Epidemiology|April 24, 2004
Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening markerMargaret Sullivan Pepe, Holly Janes, Gary Longton, et al.
Pageof 19